Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece

Αchilles Anagnostopoulos; Aikaterini Evangelopoulou; D Sotou; Dimitra Gika; Dimitrios Mitsibounas; Meletios A Dimopoulos

doi:10.1007/s00277-002-0493-0

Related publications

Chapter in a book2013

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma

Efstathios Kastritis, Meletios A Dimopoulos

Article2004

Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein

Αchilles Anagnostopoulos, Eleni Galani, Dimitra Gika, D Sotou, Aikaterini Evangelopoulou, Meletios A Dimopoulos

Article2021

Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance

Rebecca Georgakopoulou, Αngeliki Andrikopoulou, Theodoros Ν. Sergentanis, Oraianthi Fiste, Flora Zagouri, Maria Gavriatopoulou, Θεοδώρα Ψαλτοπούλου, Efstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos

Article2010

Monoclonal gammopathy of undetermined significance: a consensus statement

James R. Berenson, Kenneth C. Anderson, Robert A. Audell, Ralph V. Boccia, Morton Coleman, Meletios A Dimopoulos, Matthew T. Drake, Rafaël Fonseca, Jean‐Luc Harousseau, Douglas Joshua, Sagar Lonial, Rubén Niesvizky, Antonio Palumbo, G. David Roodman, Jesús F. San Miguel, Seema Singhal, Donna M. Weber, Maurizio Zangari, Eric Wirtschafter, Ori Yellin, Robert A. Kyle

Article2004

Role of receptor activator of nuclear factor‐kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1‐alpha (MIP‐1a) in monoclonal gammopathy of undetermined significance (MGUS)

Marianna Politou, Evangelos Terpos, Αchilles Anagnostopoulos, Richard Szydlo, Michael Laffan, Mark Layton, Jane F. Apperley, Meletios A Dimopoulos, Amin Rahemtulla